Ignite Creation Date:
2024-05-05 @ 11:52 PM
Last Modification Date:
2024-10-26 @ 10:41 AM
Study NCT ID:
NCT01437878
Status:
TERMINATED
Last Update Posted:
2015-11-20
First Post:
2011-09-20
Brief Title:
Effects of Ventavis in Patients With Pulmonary Hypertension PH Secondary to Chronic Obstructive Pulmonary Disease COPD
Sponsor:
Actelion
Organization:
Actelion
Study Overview
Official Title:
A Phase 2 Multi-center Double-blind Randomized Placebo-controlled Study to Evaluate the Effects of Inhaled Iloprost on Endurance Time During Cardiopulmonary Exercise Testing in Patients With Pulmonary Hypertension Secondary to Chronic Obstructive Pulmonary Disease
Status:
TERMINATED
Status Verified Date:
2015-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
low recruitment
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a phase 2 Multi-center double-blind randomized placebo-controlled study to evaluate the effects of inhaled Iloprost in patients with pulmonary hypertension secondary to COPD The main objective is to investigate the effect of iloprost on exercise endurance time during constant work rate cardiopulmonary exercise testing Other efficacy and safety endpoints will additionally be analyzed
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None